Skip to content
Screener

EBITDA margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
24.2%-0.2pp
Labcorp Holdings logo
Labcorp HoldingsLH
15%+1.8pp
IQVIA logo
IQVIAIQV
19.9%-1.1pp
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
2.5%+1.3pp
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-7.2%
NeoGenomics logo
NeoGenomicsNEO
-0.8%-0.4pp

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.7%
Enterprise value$16.05B+31.6%
P/E33.4×+4.5×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Calculated from Medpace Holdings, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026. Open the filing →

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025

FAQ

What is Medpace Holdings, Inc.'s EBITDA margin?
Medpace Holdings, Inc. (MEDP) reported EBITDA margin of 22% in Q2 2026.
How has Medpace Holdings, Inc.'s EBITDA margin changed year-over-year?
Medpace Holdings, Inc.'s EBITDA margin decreased by 3.2% year-over-year, from 22.7% to 22%.
What is the long-term trend for Medpace Holdings, Inc.'s EBITDA margin?
Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s EBITDA margin has grown at a 2.0% compound annual growth rate (CAGR), from 20.1% to 22.3%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Ask your AI about Medpace Holdings, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude